Fluocinolone Acetonide Implant for Patients suffering from chronic posterior non-infectious Uveitis

被引:0
|
作者
Bitzer, Michaela
机构
关键词
D O I
10.1055/a-0891-6002
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
[No abstract available]
引用
收藏
页码:841 / 841
页数:1
相关论文
共 50 条
  • [41] Comment on ‘Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal’
    Ian Jacob
    Karin Butler
    Karolina Badora
    Vanessa Gross
    Annette Beiderbeck
    Steve Morris
    Phil McEwan
    PharmacoEconomics, 2020, 38 : 645 - 648
  • [42] Controlling Posterior Segment Uveitic Recurrences: Results from a Phase 3 Study of 0.18 mg Fluocinolone Acetonide Intravitreal Insert (FAi) in Subjects with Chronic Non-Infectious Uveitis Affecting the Posterior Segment
    Quan Dong Nguyen
    Patel, Keyur
    Paggiarino, Dario A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [43] Efficacy and Safety of Fluocinolone Acetonide 0.19 mg Intravitreal Implant for the Treatment of Non-Infectious Uveitis: A Systematic Review of Real-World Evidence
    Christensen, Louise Fischer
    Hassing, Anne Kjaersgaard
    Klefter, Oliver Niels
    Vorum, Henrik
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2024,
  • [44] Long-Term Treatment Outcomes with a Single 0.19 Mg Fluocinolone Acetonide Implant in Non-Infectious Uveitis - A Real-World Study
    Darwisch, Warda
    Waizel, Maria della Volpe
    Finger, Robert Patrick
    Januschowski, Kai
    Seitz, Berthold
    Fries, Fabian Norbert
    Rickmann, Annekatrin
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2025,
  • [45] Comment on 'Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal'
    Jacob, Ian
    Butler, Karin
    Badora, Karolina
    Gross, Vanessa
    Beiderbeck, Annette
    Morris, Steve
    McEwan, Phil
    PHARMACOECONOMICS, 2020, 38 (06) : 645 - 648
  • [46] Course of Non-infectious Uveitis Affecting the Posterior Segment: Fellow-eye Data from a 3-year Study of the Fluocinolone Acetonide Intravitreal Insert
    Sharma, Sumit
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [47] Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant
    Sheppard, John D.
    Quan Dong Nguyen
    Usner, Dale W.
    Comstock, Timothy L.
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 79 - 85
  • [48] Response to Comment on "Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-Infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal"
    Pouwels, Xavier G. L. V.
    Petersohn, Svenja
    Carrera, Vanesa Huertas
    Denniston, Alastair K.
    Chalker, Annette
    Raatz, Heike
    Armstrong, Nigel
    Witlox, Willem
    Worthy, Gill
    Noake, Caro
    Riemsma, Rob
    Kleijnen, Jos
    Joore, Manuela A.
    PHARMACOECONOMICS, 2020, 38 (06) : 649 - 651
  • [49] Response to Comment on “Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-Infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal”
    Xavier G. L. V. Pouwels
    Svenja Petersohn
    Vanesa Huertas Carrera
    Alastair K. Denniston
    Annette Chalker
    Heike Raatz
    Nigel Armstrong
    Willem Witlox
    Gill Worthy
    Caro Noake
    Rob Riemsma
    Jos Kleijnen
    Manuela A. Joore
    PharmacoEconomics, 2020, 38 : 649 - 651
  • [50] Preliminary evaluation of YUTIQ™ (fluocinolone acetonide intravitreal implant 0.18 mg) in posterior uveitis
    Testi, Ilaria
    Pavesio, Carlos
    THERAPEUTIC DELIVERY, 2019, 10 (10) : 621 - 625